Globe and Mail profiles former President Jimmy Carter, Carter Center's efforts to eradiacate guinea worm

NewsGuard 100/100 Score

The Globe and Mail profiles former President Jimmy Carter and the Carter Center's decades-long efforts to eradicate guinea worm disease, also known as dracunculiasis. According to the newspaper, "In 2011, there were 1,060 cases of guinea worm disease identified in the world, in four countries," and "[s]taff and volunteers from the Carter Center have visited every one of the 26,500 villages where guinea worm was identified" to provide education on prevention, as well as treatment. "Mr. Carter is hands-on, visiting these countries and affected villages himself," and "[h]is approach is to negotiate directly with kings, presidents and rebel leaders, to get them to sign contracts" to focus on the disease's eradication, the Global and Mail writes, concluding, "It is perhaps the ultimate irony that, in making the forgotten disease of forgotten people his cause, Mr. Carter's contribution has been largely forgotten" (Picard, 4/23).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.